Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Aug 26:15:708481.
doi: 10.3389/fnhum.2021.708481. eCollection 2021.

Implantable Pulse Generators for Deep Brain Stimulation: Challenges, Complications, and Strategies for Practicality and Longevity

Affiliations

Implantable Pulse Generators for Deep Brain Stimulation: Challenges, Complications, and Strategies for Practicality and Longevity

Can Sarica et al. Front Hum Neurosci. .

Abstract

Deep brain stimulation (DBS) represents an important treatment modality for movement disorders and other circuitopathies. Despite their miniaturization and increasing sophistication, DBS systems share a common set of components of which the implantable pulse generator (IPG) is the core power supply and programmable element. Here we provide an overview of key hardware and software specifications of commercially available IPG systems such as rechargeability, MRI compatibility, electrode configuration, pulse delivery, IPG case architecture, and local field potential sensing. We present evidence-based approaches to mitigate hardware complications, of which infection represents the most important factor. Strategies correlating positively with decreased complications include antibiotic impregnation and co-administration and other surgical considerations during IPG implantation such as the use of tack-up sutures and smaller profile devices.Strategies aimed at maximizing battery longevity include patient-related elements such as reliability of IPG recharging or consistency of nightly device shutoff, and device-specific such as parameter delivery, choice of lead configuration, implantation location, and careful selection of electrode materials to minimize impedance mismatch. Finally, experimental DBS systems such as ultrasound, magnetoelectric nanoparticles, and near-infrared that use extracorporeal powered neuromodulation strategies are described as potential future directions for minimally invasive treatment.

Keywords: DBS (deep brain stimulation); IPG (implantable pulse generator); battery life; complications; longevity; neuromodulation; non-invasive; wireless charging.

PubMed Disclaimer

Conflict of interest statement

AL has consulted for Medtronic, Abbott, Boston Scientific, Insightec, Aleva and is a co-founder of Functional Neuromodulation. SK received consulting fees from Medtronic. CS has received fellowship grants from Michael and Amira Dan Foundation and Turkish Neurosurgical Society. CI-M is founder and CEO of Hyperexis and Abaxial Médical Inc. AF reports the following: consultancies from Abbvie, Medtronic, Boston Scientific, Sunovion, Chiesi farmaceutici, UCB, Ipsen; Advisory Boards of Abbvie, Boston Scientific, Ipsen; honoraria from Abbvie, Medtronic, Boston Scientific, Sunovion, Chiesi farmaceutici, UCB, Ipsen; grants from University of Toronto, Weston foundation, Abbvie, Medtronic, Boston Scientific. RM is in the advisory board of Medtronic and receives grants from Medtronic. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
Features of current commercially available internal pulse generators. Abbreviations: A, areas; C, conditional; CA, coactivation; CF, current fractionation; Freq., frequency; Hz, Hertz; IL, interleaving; LFP, local field potential; MICC, multiple independent current control; MRI, magnetic resonance imaging; MSS, multi-stim set; PC, primary cell; RC, rechargeable cell; SC, single cell; TF, temporal fractionation; U, unsafe. *Percept PC can provide independent current control across 16 electrode contacts, but this function is not yet available on physician’s programmer as of March 2021. Not all features or devices are or will be available for a given region and are subject to local regulatory approvals.
Figure 2
Figure 2
Extracorporeal powered non- to minimal-invasive DBS systems. (A) (Left) Transcranial near-infrared light can be converted to visible light by molecularly tailored upconversion nanoparticles for stimulation of genetically modified channelrhodopsin-expressing neurons (Chen et al., 2018). (Middle) Piezoelectric nanoparticles can activate neurons when they are powered using an external magnetic field (Kozielski et al., 2021) or ultrasound (Marino et al., 2015). No genetic modification is needed for this method. (Right) Another method involves activation of genetically modified heat-sensitive capsaicin receptors on neurons by heat- generating magnetic nanoparticles (Chen et al., 2015). (B) In the method by Grossman et al., multiple electric fields at frequencies too high to recruit neural firing, but which differ in frequency within the dynamic range of neural firing were delivered. The interference between the two applied fields served to cancel out the high-frequency activity but allowed the emergence of an oscillation corresponding to the difference in the two frequencies that allows electrical stimulation of the neurons in the interference region (Grossman et al., 2017). (C) Neurons can be activated by wireless, leadless, battery-free, and small (1.7 mm3 in volume) neural stimulators that are powered ultrasonically by hand-held external transceivers (Piech et al., 2020). (D) Transcranial ultrasound has the potential to be used as a neuromodulation tool even in the absence of a neurostimulator device (Fomenko et al., 2020). Reproduced with the permission of Dr. Gokhan Canaz (Cura Canaz Medical Arts).

References

    1. Abode-Iyamah K. O., Chiang H.-Y., Woodroffe R. W., Park B., Jareczek F. J., Nagahama Y., et al. . (2018). Deep brain stimulation hardware-related infections: 10-year experience at a single institution. J. Neurosurg. [Epub ahead of print]. 10.3171/2017.9.JNS1780 - DOI - PMC - PubMed
    1. Akbar U., Raike R. S., Hack N., Hess C. W., Skinner J., Martinez-Ramirez D., et al. . (2016). Randomized, blinded pilot testing of nonconventional stimulation patterns and shapes in Parkinson’s disease and essential tremor: evidence for further evaluating narrow and biphasic pulses. Neuromodulation 19, 343–356. 10.1111/ner.12397 - DOI - PMC - PubMed
    1. Almeida L., Martinez-Ramirez D., Ahmed B., Deeb W., Jesus S., Skinner J., et al. . (2017). A pilot trial of square biphasic pulse deep brain stimulation for dystonia: the BIP dystonia study. Mov. Disord. 32, 615–618. 10.1002/mds.26906 - DOI - PubMed
    1. Almeida L., Rawal P. V., Ditty B., Smelser B. L., Huang H., Okun M. S., et al. . (2016). Deep brain stimulation battery longevity: comparison of monopolar versus bipolar stimulation modes. Mov. Disord. Clin. Pract. 3, 359–366. 10.1002/mdc3.12285 - DOI - PMC - PubMed
    1. Anheim M., Batir A., Fraix V., Silem M., Chabardes S., Seigneuret E., et al. . (2008). Improvement in Parkinson disease by subthalamic nucleus stimulation based on electrode placement: effects of reimplantation. Arch. Neurol. 65, 612–616. 10.1001/archneur.65.5.612 - DOI - PubMed

LinkOut - more resources